Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

Brian M. Alexander, Paul D. Brown, Manmeet S. Ahluwalia, Hidefumi Aoyama, Brigitta G. Baumert, Susan M. Chang, Laurie E. Gaspar, Steven N. Kalkanis, David R. Macdonald, Minesh P. Mehta, Riccardo Soffietti, John H. Suh, Martin J. van den Bent, Michael A. Vogelbaum, Jeffrey S. Wefel, Eudocia Q. Lee, Patrick Y. Wen, Response Assessment Neuro-Oncology

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)E33-E42
Number of pages10
JournalLancet oncology
Volume19
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • QUALITY-OF-LIFE
  • STEREOTACTIC RADIOSURGERY
  • RADIATION-THERAPY
  • RANDOMIZED-TRIAL
  • RANO GROUP
  • NEUROCOGNITIVE FUNCTION
  • SURGICAL RESECTION
  • SINGLE METASTASES
  • RADIOTHERAPY
  • SURVIVAL

Cite this

Alexander, B. M., Brown, P. D., Ahluwalia, M. S., Aoyama, H., Baumert, B. G., Chang, S. M., Gaspar, L. E., Kalkanis, S. N., Macdonald, D. R., Mehta, M. P., Soffietti, R., Suh, J. H., van den Bent, M. J., Vogelbaum, M. A., Wefel, J. S., Lee, E. Q., Wen, P. Y., & Response Assessment Neuro-Oncology (2018). Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet oncology, 19(1), E33-E42. https://doi.org/10.1016/S1470-2045(17)30692-7